Literature DB >> 19561786

Severe migratory Angioedema due to ACE inhibitors use.

G Peltekis1, D Palaskas, M Samanidou, A Fragakis, K Alexopoulos, A Kotsani, I Vogiatzis, E Kyrmizakis.   

Abstract

Angioedema due to use of angiotensin-converting enzyme inhibitors (ACEIs) is a rare side-effect but is seen more often because of the increase in the use of these drugs due to their effectiveness and good tolerance in the treatment of hypertension and congestive heart failure. Other types of angioedema, which should be included in the differential diagnosis, are the hereditary type, which results from deficiency of C1 esterase inhibitor and the allergic angioedema. Angioedema is a potentially life-threatening condition when it is located to the mucosal and submucosal layers of the upper airway. Some times an angioedema case can be very severe, resistant to the usual treatment and even rarely fatal. The last eight months, six patients with angioedema due to ACEIs (5 cases) or angiotensin II receptor blockers (1 case), were examined and hospitalized at our department. We describe the case of a 65 year old woman with severe migratory angioedema of the tongue, the floor of the mouth and the oropharynx, which was rather resistant to the usual treatment.

Entities:  

Keywords:  ACE inhibitors; angioedema

Year:  2009        PMID: 19561786      PMCID: PMC2683457     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  11 in total

Review 1.  Losartan: first of a new class of angiotensin antagonists for the management of hypertension.

Authors:  A A Carr; L M Prisant
Journal:  J Clin Pharmacol       Date:  1996-01       Impact factor: 3.126

Review 2.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.

Authors:  Dionysios E Kyrmizakis; Chariton E Papadakis; Antonios D Liolios; Alexandros D Karatzanis; Stylianos Malandrakis; Charalambos E Skoulakis; John G Bizakis; George A Velegrakis
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-12

3.  Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor.

Authors:  H L Chin; D A Buchan
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

4.  Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.

Authors:  A G Chiu; E J Krowiak; Z E Deeb
Journal:  Laryngoscope       Date:  2001-10       Impact factor: 3.325

5.  Tongue angioedema after long-term use of ACE inhibitors.

Authors:  D E Kyrmizakis; C E Papadakis; E J Fountoulakis; A D Liolios; J G Skoulas
Journal:  Am J Otolaryngol       Date:  1998 Nov-Dec       Impact factor: 1.808

Review 6.  Adverse effects of the angiotensin-converting enzyme inhibitors.

Authors:  C P Alderman
Journal:  Ann Pharmacother       Date:  1996-01       Impact factor: 3.154

7.  Angioedema secondary to angiotensin-converting enzyme inhibitors.

Authors:  J P Pracy; J A McGlashan; R M Walsh; M J Gleeson
Journal:  J Laryngol Otol       Date:  1994-08       Impact factor: 1.469

8.  Captopril-induced angioedema.

Authors:  G K Jett
Journal:  Ann Emerg Med       Date:  1984-06       Impact factor: 5.721

9.  Angioneurotic edemas of the upper aerodigestive tract after ACE-inhibitor treatment.

Authors:  M Tisch; L Lampl; A Groh; H Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-05-24       Impact factor: 2.503

10.  Angioedema of the head and neck.

Authors:  A Haddad; S Frenkiel; P Small
Journal:  J Otolaryngol       Date:  1985-02
View more
  2 in total

1.  A case report looking at ACE inhibitors as the cause of angioedema during dental treatment.

Authors:  P Raval
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

2.  Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor.

Authors:  Acílio Marques; Carla Retroz-Marques; Sara Mota; Raquel Cabral; Matos Campos
Journal:  Case Rep Anesthesiol       Date:  2014-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.